# IRulya Therapeutics (IRLA) — Overview

IRLA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/irla

## Price

Last close $27.00 on Oct 12, 2026. 52-week range $27.00 – $27.00.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | −$75.5M |
| Net income growth (year over year) | -370.36% |
| Net margin | 0.00% |
| Return on equity | -153.84% |
| EPS (trailing twelve months) | −$210.84 |
| Book value per share | $106.67 |
| P/E (trailing twelve months) | — |
| Price to book | 0.3 |
| Debt to assets | 12.51% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### How do I buy stock in IRulya Therapeutics (IRLA)?

IRLA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).